Joy M Schmitz Selected Research

Tobacco Use Cessation Devices

1/2021

Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joy M Schmitz Research Topics

Disease

18	Cocaine-Related Disorders (Cocaine Addiction) 01/2016 - 07/2004
10	Substance-Related Disorders (Drug Abuse) 10/2021 - 11/2006
7	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2016
5	Wounds and Injuries (Trauma) 02/2022 - 01/2016
5	Alcoholism (Alcohol Abuse) 05/2019 - 07/2004
4	Anhedonia 10/2022 - 01/2017
4	Opioid-Related Disorders (Opiate Addiction) 02/2022 - 10/2008
2	Pain (Aches) 02/2022 - 01/2022
2	Cognitive Dysfunction 12/2021 - 01/2021
2	Gambling (Pathological Gambling) 01/2021 - 07/2010
2	Inflammation (Inflammations) 01/2021 - 02/2020
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2015 - 11/2009
2	Antisocial Personality Disorder (Antisocial Personality) 01/2009 - 01/2002
1	Syndrome (Syndromes) 10/2021
1	Weight Gain 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Overweight 01/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2019
1	Bradycardia 01/2016
1	Atherosclerosis 01/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Neoplasms (Cancer) 01/2014
1	Weight Loss (Weight Reduction) 04/2009
1	Marijuana Use 01/2009
1	Dizziness (Lightheadedness) 05/2007
1	Nausea 05/2007
1	Alcohol-Related Disorders 02/2004

Drug/Important Bio-Agent (IBA)

27	Cocaine (Cocaine HCl)IBA 12/2021 - 07/2004
10	Pharmaceutical PreparationsIBA 10/2022 - 01/2002
5	Levodopa (L Dopa)FDA LinkGeneric 01/2017 - 05/2007
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2014
3	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 05/2007
3	Naltrexone (ReVia)FDA LinkGeneric 11/2009 - 07/2004
2	Opioid Analgesics (Opioids)IBA 02/2022 - 01/2022
2	TESIBA 01/2017 - 06/2015
2	Carbidopa (Lodosyn)FDA LinkGeneric 07/2014 - 05/2007
2	Methamphetamine (Desoxyn)FDA LinkGeneric 04/2009 - 10/2008
2	Nicotine FDA Link 10/2008 - 02/2004
1	MMEIBA 02/2022
1	Morphine (MS Contin)FDA LinkGeneric 02/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	AldehydesIBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Orexin ReceptorsIBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2019
1	N-nitrosoiminodiacetic acidIBA 01/2018
1	A-factor (Streptomyces)IBA 01/2016
1	Cytidine Diphosphate Choline (Citicoline)IBA 10/2015
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2014
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2012
1	Modafinil (Provigil)FDA Link 01/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 04/2009
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2007
1	Serotonin (5 Hydroxytryptamine)IBA 01/2007
1	Citalopram FDA LinkGeneric 01/2007

Therapy/Procedure

11	Therapeutics 05/2019 - 07/2004
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
2	Length of Stay 02/2022 - 01/2015
2	Transjugular Intrahepatic Portasystemic Shunt 05/2019 - 01/2018
1	Tobacco Use Cessation Devices 01/2021
1	Nicotine Replacement Therapy 01/2021
1	Ambulatory Care (Outpatient Care) 02/2007
1	Secondary Prevention 07/2004